Tag: Merck

The Merck Group, branded and commonly known as Merck, is a German multinational chemical, pharmaceutical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

Accelerating Sales of Mavenclad Helped Mrck to Double-Digit Rise in Healthcare Sales

Accelerating sales of Merck KGaA’s oral multiple sclerosis therapy Mavenclad helped the company to a double-digit rise in healthcare sales in the third quarter, and a rise in its full-year revenue for...

Merck Agreed to Provide Evotec Access to CRISPR Gene-Editing Technology

gene therapy
Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an inte...

Merck Acquired COI Pharmaceuticals for $576m

COI Pharmaceuticals, the Community Of Innovation established by Avalon Ventures, today announced the acquisition of Calporta Therapeutics, Inc. by Merck, known as MSD outside the United States and Can...

Gossamer Bio Entered into Clinical Collaboration Agreement with Merck

merck kgaa
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, announced that it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to evaluate th...

Clinical Study of Avelumab Didn’t Met Primary Endpoints

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelu...

Merck Sales Top $3bn in 3Q2019

Merck & Co Inc said it expected immunotherapy Keytruda to continue its market dominance as an initial treatment for advanced lung cancer as sales of the drug topped $3 billion in a quarter for the...

EC Approved BAVENCIO® for Advanced Renal Cell Carcinoma Treatment

merck kgaa
Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. announced that the European Commission (EC) has approved BAVENCIO® (av...

Merck Launched Seed Fund to Promote Startups in China

Another innovation hub, in the southern city of Guangzhou, is planned for November. To date, six startups in China and other Asian countries have taken part in the German drugmaker's accelerator pro...

Merck to Cut 500 US Jobs Next Year

Merck & Co. is eliminating approximately 500 positions in multiple US states as of January 3, 2020, according to a filing with the Pennsylvania Department of Labor and Industry. "This is not ...

Merck’s KEYTRUDA Approved by NMPA in China

Merck, known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products Administration (NMPA) in China as monot...

Eisai and Merck Announced Final Results from Study Evaluating LENVIMA plus KEYTRUDA

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A., known as MSD outside the United States and Canada, announced final results from the full endometrial cancer cohort of KEYNOTE-146/Study 111 e...

AstraZeneca and Merck’s LYNPARZA® Phase 3 PAOLA-1 Trial Presented

astrazeneca
AstraZeneca and Merck, known as MSD outside the United States and Canada, announced detailed positive results from the Phase 3 PAOLA-1 trial showing LYNPARZA added to bevacizumab demonstrated a statis...

FDA Approved Merck’s sNDA for PIFELTRO™ and DELSTRIGO™

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO™ (in combination w...

Merck’s Investigational V920 Ebola Zaire Vaccine Accepted for Priority Review

ebola-vaccine
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted priority rev...

FDA Approved Merck’s Lenvima Under New Project Orbis

The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE). Project Orbis provides a framework for concurrent submission and review...

FDA Granted Merck’s Tepotinib Breakthrough Therapy Designation

Merck, a leading science and technology company, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational targeted therapy tepotini...